Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

C James Mullen

Affiliations

  • Director at Editas Medicine Inc. (EDIT), 2019-06-14
  • Director at Thermo Fisher Scientific Inc. (TMO), 2019-05-23
  • Director at Insulet Corp (PODD), 2018-05-18
  • Chief Executive Officer at Patheon N.v. (PTHN), 2017-08-31
  • Director at Perkinelmer Inc (PKI), 2014-11-17
  • Chief Executive Officer at Patheon Inc (PTI), 2014-03-12
  • Ceo & President at Biogen Idec Inc. (BIIB), 2010-06-10
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EDIT $38.03 10,000 Director 10,000 2018-05-18 Filing
PODD $67.45 2,500 Director 5,598 2017-11-13 Filing
PTI $1.86 194,759 Officer, Director 1,201,044 2012-03-19 Filing
PTI $1.88 5,000 Officer, Director 1,006,285 2012-03-16 Filing
PTI $1.70 1,400 Officer, Director 1,001,285 2012-03-14 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PKI $43.73 8,892 Director 45,551 2014-11-14 Filing
PKI $43.73 12,951 Director 43,178 2014-02-07 Filing
PKI $30.31 6,440 Director 39,915 2013-04-30 Filing
PKI $26.85 5,865 Director 36,335 2012-02-21 Filing
PKI $24.00 10,000 Director 32,791 2010-11-04 Filing